Literature DB >> 28978971

Editorial: Autoimmune Pancreatitis in Children: Is This a New Subtype of Disease or Early-Onset Idiopathic Duct-Centric Chronic Pancreatitis?

Phil A Hart1, Suresh T Chari2.   

Abstract

The term autoimmune pancreatitis (AIP) encompasses two distinct steroid-responsive pancreatitides, type 1 AIP and idiopathic duct-centric pancreatitis (IDCP) (or type 2 AIP). The current study describes cases of both AIP subtypes in a pediatric population. A comparison of the clinical profile of the described cohort with published data strongly suggests the majority of patients in the current cohort had IDCP. Since relapse rates in IDCP are low and long-term maintenance therapy is not required for IDCP, this has implications for prognosis and therapy. However, longer follow-up is needed to more accurately determine if onset during childhood leads to a different disease course.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28978971     DOI: 10.1038/ajg.2017.236

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis.

Authors:  Raghuwansh P Sah; Suresh T Chari; Rahul Pannala; Aravind Sugumar; Jonathan E Clain; Michael J Levy; Randall K Pearson; Thomas C Smyrk; Bret T Petersen; Mark D Topazian; Naoki Takahashi; Michael B Farnell; Santhi S Vege
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

2.  International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology.

Authors:  Tooru Shimosegawa; Suresh T Chari; Luca Frulloni; Terumi Kamisawa; Shigeyuki Kawa; Mari Mino-Kenudson; Myung-Hwan Kim; Günter Klöppel; Markus M Lerch; Matthias Löhr; Kenji Notohara; Kazuichi Okazaki; Alexander Schneider; Lizhi Zhang
Journal:  Pancreas       Date:  2011-04       Impact factor: 3.327

Review 3.  Autoimmune Pancreatitis in Children: Characteristic Features, Diagnosis, and Management.

Authors:  Isabelle Scheers; Joseph J Palermo; Steven Freedman; Michael Wilschanski; Uzma Shah; Maisam Abu-El-Haija; Bradley Barth; Douglas S Fishman; Cheryl Gariepy; Matthew J Giefer; Melvin B Heyman; Ryan W Himes; Sohail Z Husain; Tom K Lin; Quin Liu; Mark Lowe; Maria Mascarenhas; Veronique Morinville; Chee Y Ooi; Emily R Perito; David A Piccoli; John F Pohl; Sarah J Schwarzenberg; David Troendle; Steven Werlin; Bridget Zimmerman; Aliye Uc; Tanja Gonska
Journal:  Am J Gastroenterol       Date:  2017-04-04       Impact factor: 10.864

4.  Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis (type 2 autoimmune pancreatitis): the Mayo Clinic experience.

Authors:  Phil A Hart; Michael J Levy; Thomas C Smyrk; Naoki Takahashi; Barham K Abu Dayyeh; Jonathan E Clain; Ferga C Gleeson; Randall K Pearson; Bret T Petersen; Mark D Topazian; Santhi S Vege; Lizhi Zhang; Suresh T Chari
Journal:  Gut       Date:  2015-06-17       Impact factor: 23.059

Review 5.  Recent Advances in Autoimmune Pancreatitis.

Authors:  Phil A Hart; Yoh Zen; Suresh T Chari
Journal:  Gastroenterology       Date:  2015-03-12       Impact factor: 22.682

6.  Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis.

Authors:  Phil A Hart; Terumi Kamisawa; William R Brugge; Jae Bock Chung; Emma L Culver; László Czakó; Luca Frulloni; Vay Liang W Go; Thomas M Gress; Myung-Hwan Kim; Shigeyuki Kawa; Kyu Taek Lee; Markus M Lerch; Wei-Chih Liao; Matthias Löhr; Kazuichi Okazaki; Ji Kon Ryu; Nicolas Schleinitz; Kyoko Shimizu; Tooru Shimosegawa; Roy Soetikno; George Webster; Dhiraj Yadav; Yoh Zen; Suresh T Chari
Journal:  Gut       Date:  2012-12-11       Impact factor: 23.059

  6 in total
  1 in total

Review 1.  Type 2 Autoimmune Pancreatitis: Consensus and Controversies.

Authors:  Yoh Zen
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.